Kexing Biopharm | Finanzwire

Basculer en Français

10514	Companies
221724	Keywords
150896	Articles
117262	Press releases

Home
Companies
Kexing Biopharm

BRIEF

published on 06/04/2026 at 13:20, 2 hours 29 minutes ago

Kexing Biopharm Advances GB10 in Phase I Clinical Trial in China

Phase I Trial Patient Compliance Ophthalmic Drug GB10 NAMD Treatment
PRESS RELEASE

published on 06/04/2026 at 13:15, 2 hours 34 minutes ago

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
Kexing Biopharm enrolls first subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10, marking a significant milestone in innovative drug R&D pipeline

Phase I Clinical Trial Neovascular Age-Related Macular Degeneration Kexing Biopharm GB10 Ophthalmic Innovative Drug
BRIEF

published on 10/31/2025 at 12:30, 7 months 4 days ago

Kexing Biopharm Explores Global Expansion at CPHI Frankfurt 2025

Biopharmaceutical Innovation Global Strategy Pharmaceutical Expansion Kexing Biopharm CPHI Frankfurt
PRESS RELEASE

published on 10/31/2025 at 12:25, 7 months 4 days ago

Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025
Kexing Biopharm presents global strategy and partnerships at CPHI Frankfurt 2025, showcasing pharmaceutical capabilities and international collaborations for high-quality healthcare solutions

Healthcare Solutions Pharmaceutical International Collaboration Kexing Biopharm CPHI Frankfurt 2025

Accesswire

Published on 06/04/2026 at 14:45, 1 hour 4 minutes ago

Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026
Published on 06/04/2026 at 14:30, 1 hour 19 minutes ago

Predictiv AI's Shift Technologies Secures Multi-Phase Commercial Contract to Digitize and Scale Middle-Mile and Last-Mile Logistics for Prompt Xpress
Published on 06/04/2026 at 14:00, 1 hour 49 minutes ago

Horizon Aircraft Appoints Richard Alexander as Chief Engineer of Certified Programs
Published on 06/04/2026 at 14:00, 1 hour 49 minutes ago

GameSquare Issues Shareholder Letter Highlighting Strong Second Quarter and Year-to-Date Momentum
Published on 06/04/2026 at 14:00, 1 hour 49 minutes ago

EQ Works Expands ClearLake Platform with AI-Powered Audience Segments

View all ACCESSWIRE

EQS Group

Published on 06/04/2026 at 15:39, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: easyJet plc
Published on 06/04/2026 at 15:38, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 06/04/2026 at 15:37, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bodycote plc
Published on 06/04/2026 at 15:37, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 06/04/2026 at 15:36, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 06/04/2026 at 07:50, 7 hours 59 minutes ago

Schneider Electric launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2034 for a nominal amount of €800 million and a concurrent repurchase of its outstanding OCEANEs due 2030 by way of a re
Published on 06/03/2026 at 18:02, 21 hours 46 minutes ago

Information concerning the total number of voting rights and shares 2026 05 31
Published on 06/03/2026 at 17:45, 22 hours 4 minutes ago

Manitou Group signs an amendment to its Sustainability Linked Loan (SLL) credit agreement to align its ESG criteria with its LIFT strategy
Published on 06/03/2026 at 17:45, 22 hours 4 minutes ago

VOGO has won all lots in the National Rugby League’s latest call for tenders and has signed a strategic six-season partnership.
Published on 06/03/2026 at 17:45, 22 hours 4 minutes ago

Report on share repurchases from 27 May to 2 June 2026

View all LES ECHOS COMFI WIRE